Molecular Analysis Identifies A Subset Of Non-small Cell Lung Cancer Patients With Differential Sensitivity To Histone Deacetylase Inhibitor (hdaci)/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (egfr-tki) Treatment

被引：0
|
作者：
Jotte, R. M. [1 ]
Witta, S. E. [2 ]
Spira, A. I. [3 ]
Neubauer, M. A. [4 ]
Konduri, K. [5 ]
Ruxer, R. L. [6 ]
Hirsch, F. R. [7 ]
机构：
[1] Rocky Mt Canc Ctr, Denver, CO USA
[2] Mt Blue Canc Care Ctr, Wheat Ridge, CO USA
[3] Virginia Canc Specialists, INOVA Thorac Oncol Program, Fairfax, VA USA
[4] Kansas City Canc Ctr, Overland Pk, KS USA
[5] Baylor Sammons Canc Ctr, Dallas, TX USA
[6] SW Ft Worth Canc Ctr, Ft Worth, TX USA
[7] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S559 / S560
页数：2
相关论文
共 50 条
  • [41] Management of non-small cell lung cancer with resistance to epidermal growth factor receptor tyrosine kinase inhibitor: case discussion
    Zheng, Yuyan
    Zhou, Min
    Arulananda, Surein
    Um, Sang-Won
    Li, Hecheng
    JOURNAL OF THORACIC DISEASE, 2020, 12 (03) : 159 - 164
  • [42] Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer
    Kurihara, Eisuke
    Shien, Kazuhiko
    Torigoe, Hidejiro
    Takeda, Tatsuaki
    Takahashi, Yuta
    Ogoshi, Yusuke
    Yoshioka, Takahiro
    Namba, Kei
    Sato, Hiroki
    Suzawa, Ken
    Yamamoto, Hiromasa
    Soh, Junichi
    Okazaki, Mikio
    Shien, Tadahiko
    Tomida, Shuta
    Toyooka, Shinichi
    ANTICANCER RESEARCH, 2019, 39 (04) : 1767 - 1775
  • [43] EGFR TYROSINE KINASE INHIBITOR USED IN NON-SMALL CELL LUNG CANCER
    Joshi, Pooja
    Singh, Anita
    Bisht, Dheeraj
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (03): : 1033 - 1041
  • [44] Tyrosine Kinase Inhibitor (TKI) Real-World Use in Epidermal Growth Factor Receptor Mutated (EGFRm) Advanced Non-small Cell Lung Cancer (NSCLC) Patients
    Minatta, Jose
    Samol, Jens
    Moiseenko, Fedor
    Demedts, Ingel
    Kozlov, Vadim
    Mark, Michael
    Rajappa, Senthil
    Kahangire, Doreen A.
    Madondo, Mutsa
    Bailey, Tom
    Wallis, Hannah
    Erman, Mustafa
    Zukin, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S9 - S9
  • [45] SERUM PROTEIN LEVELS MAY BE USEFUL IN SELECTING TREATMENT WITH AN EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR (EGFR TKI) VERSUS CHEMOTHERAPY IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Fidler, Mary J.
    Karmali, Reem
    Batus, Marta
    Mahon, Brett
    Rouhi, Omid
    Shersher, David D.
    Fhied, Cristina
    Walters, Kelly
    Bonomi, Philip
    Borgia, Jeffrey A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1113 - S1114
  • [46] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Kujtan, Lara
    Subramanian, Janakiraman
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 547 - 559
  • [47] Epidermal growth factor receptor (EGFR) gene amplification in non-small cell lung cancer (NSCLC): molecular patterns and sensitivity to tyrosine kinase inhibitors
    Skokan, Margaret C.
    Gajapathy, Sujatha
    Xiao, Yun
    Franklin, Wilbur A.
    Hirsch, Fred R.
    Bunn, Paul A., Jr.
    Varella-Garcia, Marileila
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S322 - S322
  • [48] Efficacy of first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone or in combination with chemotherapy for advanced non-small cell lung cancer (NSCLC) with low-abundance mutation
    Yan, Xiangtao
    Wang, Huijuan
    Li, Peng
    Zhang, Guowei
    Zhang, Mina
    Yang, Jinpo
    Zhang, Xiaojuan
    Zheng, Xuanxuan
    Ma, Zhiyong
    LUNG CANCER, 2019, 128 : 6 - 12
  • [49] Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance
    Tartarone, Alfredo
    Lerose, Rosa
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (05) : 242 - 250
  • [50] Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial
    Kris, MG
    Natale, RB
    Herbst, RS
    Lynch, TJ
    Prager, D
    Belani, CP
    Schiller, JH
    Kelly, K
    Spiridonidis, H
    Sandler, A
    Albain, KS
    Cella, D
    Wolf, MK
    Averbuch, SD
    Ochs, JJ
    Kay, AC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (16): : 2149 - 2158
12345